ARYx Therapeutics, Inc. (ARYX)
USD 0.0
(-0.0%)
USD 0.0
(-0.0%)
| Breakdown | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|
| Revenue | - | 19.72 Million | 4.15 Million | 4.73 Million | - | - |
| Cost of Revenue | - | 232 Thousand | 262 Thousand | 2.11 Million | - | - |
| Gross Profit | - | 19.49 Million | 3.89 Million | 2.62 Million | - | - |
| Operating Expenses | 31.23 Million | 49.9 Million | 32.69 Million | 30.91 Million | 28.16 Million | -20.82 Million |
| Selling, General and Administrative Expenses | 10.19 Million | 9.76 Million | 7.7 Million | 6.93 Million | 5.67 Million | - |
| Research and Development Expenses | 21.04 Million | 40.14 Million | 24.99 Million | 23.97 Million | 22.49 Million | - |
| Other Expenses | - | - | - | - | - | -20.82 Million |
| Cost and Expenses | 31.23 Million | 50.14 Million | 32.95 Million | 33.02 Million | 28.16 Million | -20.82 Million |
| Operating Income | -31.23 Million | -30.41 Million | -28.8 Million | -28.28 Million | -28.16 Million | -20.82 Million |
| Interest Expense | 2 Million | 1.92 Million | 1.35 Million | 1.32 Million | 671 Thousand | - |
| Income Tax Expense | 849 Thousand | 801 Thousand | -1.23 Million | -960 Thousand | -205 Thousand | 20.82 Million |
| Earnings before Tax | - | - | - | - | - | - |
| Net Income | -33.16 Million | -31.21 Million | -27.56 Million | -27.32 Million | -27.96 Million | -20.82 Million |
| Earnings Per Share Basic | -1.21 | -1.65 | -8.24 | -26.84 | -30.73 | -24.27 |
| Earnings Per Share Diluted | -1.21 | -1.65 | -8.24 | -26.84 | -30.73 | -24.27 |
| Weighted Average Shares Outstanding | 27.43 Million | 18.96 Million | 3.34 Million | 1.01 Million | 910 Thousand | 858 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 27.43 Million | 18.96 Million | 3.34 Million | 1.01 Million | 910 Thousand | 858 Thousand |
| Gross Margin | - | 0.99 | 0.94 | 0.55 | - | - |
| EBIT Margin | - | -1.47 | -6.63 | -5.78 | - | - |
| Profit Margin | - | -1.58 | -6.63 | -5.77 | - | - |
| EBITDA | -30.06 Million | -29.32 Million | -27.56 Million | -27.36 Million | -26.72 Million | -20.82 Million |
| Earnings Before Tax Margin | - | -1.54 | -6.93 | -5.97 | - | - |
| Breakdown | 2010 Q3 | 2010 Q2 | 2010 Q1 | 2009 Q4 | 2009 FY | 2009 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 2.14 Million | 3.24 Million | 6.01 Million | 5.32 Million | 31.23 Million | 7.63 Million |
| Selling, General and Administrative Expenses | 1.31 Million | 2.23 Million | 3.77 Million | 2.33 Million | - | 2.63 Million |
| Research and Development Expenses | 829 Thousand | 1 Million | 2.24 Million | 2.98 Million | - | 4.99 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 2.14 Million | 3.24 Million | 6.01 Million | 5.32 Million | 31.23 Million | 7.63 Million |
| Operating Income | -2.14 Million | -3.24 Million | -6.01 Million | -5.32 Million | -31.23 Million | -7.63 Million |
| Interest Expense | 375 Thousand | 389 Thousand | 434 Thousand | 492 Thousand | 2 Million | 519 Thousand |
| Income Tax Expense | 369 Thousand | 394 Thousand | 371 Thousand | 466 Thousand | 849 Thousand | 248 Thousand |
| Earnings before Tax | - | - | - | - | - | - |
| Net Income | -2.51 Million | -3.63 Million | -6.39 Million | -5.78 Million | -33.16 Million | -8.15 Million |
| Earnings Per Share Basic | -0.08 | -0.11 | -0.22 | -0.21 | - | -0.30 |
| Earnings Per Share Diluted | -0.08 | -0.11 | -0.22 | -0.21 | - | -0.30 |
| Weighted Average Shares Outstanding | 33.45 Million | 33.45 Million | 29.34 Million | 27.59 Million | 27.43 Million | 27.44 Million |
| Weighted Average Shares Outstanding (Diluted) | 33.45 Million | 33.45 Million | 29.34 Million | 27.59 Million | 27.43 Million | 27.44 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -1.93 Million | -3.01 Million | -5.76 Million | -5.06 Million | - | -7.63 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
WOSSF
600679
AREC
0QLD
GNMSF
QNBFB